Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.The global CAR T-Cell Therapy market size was US$ 1720.6 million in 2023 and is forecast to a readjusted size of US$ 13510 million by 2030 with a CAGR of 29.9% during the forecast period 2024-2030. Fully considering the economic change by this health crisis, CD19 - Targeted accounting for % of the CAR T-Cell Therapy global market in 2023, is projected to value US$ million by 2030, growing at a revised % CAGR from 2024 to 2030. While Lymphoma segment is altered to an % CAGR throughout this forecast period.
Global Market Research Publisher QYResearch (QY Research) announces the release of its latest report “CAR T-Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”. Based on 2024 market situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global CAR T-Cell Therapy market, including market size, market share, market volume, demand, industry development status, and forecasts for the next few years.
The report provides advanced statistics and information on global market conditions and studies the strategic patterns adopted by renowned players across the globe. As the market is constantly changing, the report explores competition, supply and demand trends, as well as the key factors that contribute to its changing demands across many markets.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/2705964/car-t-cell-therapy
Global CAR T-Cell Therapy Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends, providing a detailed analysis of the production volume for each type from 2019 to 2030, as well as the production volume by region during the same period.
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The CAR T-Cell Therapy market is segmented as below:
By Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Segment by Type
CD19 - Targeted
BCMA - Targeted
Segment by Application
Lymphoma
Multiple Myeloma
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Safe Deposit Boxes（Safety Deposit Boxes) market?
- What factors are driving Safe Deposit Boxes（Safety Deposit Boxes) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Safe Deposit Boxes（Safety Deposit Boxes) market opportunities vary by end market size?
- How does Safe Deposit Boxes（Safety Deposit Boxes) break out by Type, by Application?
Each chapter of the report provides detailed information for readers to further understand the CAR T-Cell Therapy market:
Chapter One: Introduces the study scope of this report, executive summary of market segment by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Two: Detailed analysis of CAR T-Cell Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of CAR T-Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Table of Contents
1 CAR T-Cell Therapy Market Overview
1.1 CAR T-Cell Therapy Product Overview
1.2 CAR T-Cell Therapy Market by Type
1.3 Global CAR T-Cell Therapy Market Size by Type
1.3.1 Global CAR T-Cell Therapy Market Size Overview by Type (2019-2030)
1.3.2 Global CAR T-Cell Therapy Historic Market Size Review by Type (2019-2024)
1.3.3 Global CAR T-Cell Therapy Forecasted Market Size by Type (2025-2030)
1.4 Key Regions Market Size by Type
1.4.1 North America CAR T-Cell Therapy Sales Breakdown by Type (2019-2024)
1.4.2 Europe CAR T-Cell Therapy Sales Breakdown by Type (2019-2024)
1.4.3 Asia-Pacific CAR T-Cell Therapy Sales Breakdown by Type (2019-2024)
1.4.4 Latin America CAR T-Cell Therapy Sales Breakdown by Type (2019-2024)
1.4.5 Middle East and Africa CAR T-Cell Therapy Sales Breakdown by Type (2019-2024)
2 CAR T-Cell Therapy Market Competition by Company
2.1 Global Top Players by CAR T-Cell Therapy Sales (2019-2024)
2.2 Global Top Players by CAR T-Cell Therapy Revenue (2019-2024)
2.3 Global Top Players by CAR T-Cell Therapy Price (2019-2024)
2.4 Global Top Manufacturers CAR T-Cell Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 CAR T-Cell Therapy Market Competitive Situation and Trends
2.5.1 CAR T-Cell Therapy Market Concentration Rate (2019-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by CAR T-Cell Therapy Sales and Revenue in 2023
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2023)
2.7 Date of Key Manufacturers Enter into CAR T-Cell Therapy Market
2.8 Key Manufacturers CAR T-Cell Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
...
Overall, this report strives to provide you with the insights and information you need to make informed business decisions and stay ahead of the competition.
To contact us and get this report: https://www.qyresearch.com/contact-us
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please Contact us:
QY Research Inc. (QYResearch)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)
EN: https://www.qyresearch.com
JP: https://www.qyresearch.co.jp